---
content_type: page
description: This section contains a list of readings by week and includes links to
  lecture summaries and online journal articles.
hide_download: true
hide_download_original: null
learning_resource_types:
- Readings
ocw_type: CourseSection
title: Readings
uid: 7e163d7b-0bbf-2a37-2c6c-f5874f31469c
---

{{< tableopen >}}
{{< theadopen >}}
{{< tropen >}}
{{< thopen >}}
WEEK #
{{< thclose >}}
{{< thopen >}}
TOPICS
{{< thclose >}}
{{< thopen >}}
READINGS
{{< thclose >}}

{{< trclose >}}

{{< theadclose >}}
{{< tropen >}}
{{< tdopen >}}
1
{{< tdclose >}}
{{< tdopen >}}


Introduction

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm1" %}}


{{< tdclose >}}
{{< tdopen >}}
No Readings
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
2
{{< tdclose >}}
{{< tdopen >}}


Of tumor suppressors and oncogenes

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm2" %}}


{{< tdclose >}}
{{< tdopen >}}


Schwab, M., J. Ellison, et al. "[Enhanced Expression of the Human Gene N–myc Consequent to Amplification of DNA may Contribute to Malignant Progression of Neuroblastoma](http://www.ncbi.nlm.nih.gov/pubmed/6589638)." _Proceedings of the National Academy of Sciences_ 81, no. 15 (1984): 4940–44.

Baker, S. J., S. Markowitz, et al. "[Suppression of Human Colorectal Carcinoma Cell Growth by Wild–type p53](http://dx.doi.org/10.1126/science.2144057)." _Science_ 249, no. 4971 (1990): 912–15.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
3
{{< tdclose >}}
{{< tdopen >}}


Cancer stem cells and minimal residual disease

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm3" %}}


{{< tdclose >}}
{{< tdopen >}}


Lapidot, T., C. Sirard, et al. "[A Cell Initiating Human Acute Myeloid Leukaemia after Transplantation into SCID Mice](http://dx.doi.org/10.1038/367645a0)." _Nature_ 367, no. 6464 (1994): 645–48.

Gerber, J. M., B. D. Smith, et al. "[A Clinically Relevant Population of Leukemic CD34{{< sup "\+" >}}CD38{{< sup "–" >}} Cells in Acute Myeloid Leukemia](http://dx.doi.org/10.1182/blood-2011-06-364182)." _Blood_ 119, no. 15 (2012): 3571–77.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
4
{{< tdclose >}}
{{< tdopen >}}


Can we model human cancers in mice?

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm4" %}}


{{< tdclose >}}
{{< tdopen >}}


Harris, A. W., C. A. Pinkert, et al. "[The E Mu–myc Transgenic Mouse. A Model for High–incidence Spontaneous Lymphoma and Leukemia of Early B Cells](http://dx.doi.org/10.1084/jem.167.2.353)." _The Journal of Experimental Medicine_ 167, no. 2 (1988): 353–71.

Ishikawa, F., S. Yoshida, et al. "[Chemotherapy–resistant Human AML Stem Cells Home to and Engraft within the Bone–marrow Endosteal Region](http://dx.doi.org/10.1038/nbt1350)." _Nature Biotechnology_ 25, no. 11 (2007): 1315–21.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
5
{{< tdclose >}}
{{< tdopen >}}


Making a better Mouse Man—Recent developments in humanized mouse technologies

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm5" %}}


{{< tdclose >}}
{{< tdopen >}}


Shultz, Leonard D., Yoriko Saito, et al. "[Generation of Functional Human T–cell Subsets with HLA–restricted Immune Responses in HLA Class I Expressing NOD/SCID/IL2rγ{{< sup "null" >}} Humanized Mice](http://dx.doi.org/10.1073/pnas.1000475107)." _Proceedings of the National Academy of Sciences_ 107, no. 29 (2010): 13022–27.

Lan, P., N. Tonomura, et al. "[Reconstitution of a Functional Human Immune System in Immunodeficient Mice through Combined Human Fetal Thymus / Liver and CD34{{< sup "\+" >}} Cell Transplantation](http://dx.doi.org/10.1182/blood-2005-11-4388)." _Blood_ 108, no. 2 (2006): 487–92.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
6
{{< tdclose >}}
{{< tdopen >}}


Sophisticated models of _de novo_ human tumors in humanized mice

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm6" %}}


{{< tdclose >}}
{{< tdopen >}}


Moriya, K., M. Suzuki, et al. "[Development of a Multi–step Leukemogenesis Model of MLL–rearranged Leukemia using Humanized Mice](http://dx.doi.org/10.1371/journal.pone.0037892)." _PLoS One_ 7, no. 6 (2012): e37892.

Washburn, M. L., M. T. Bility, et al. "[A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease.](http://dx.doi.org/10.1053/j.gastro.2011.01.001)" _Gastroenterology_ 140, no. 4 (2011): 1334–44.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
7
{{< tdclose >}}
{{< tdopen >}}


Visit to Chen Research Lab

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm7" %}}


{{< tdclose >}}
{{< tdopen >}}
No Readings
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
8
{{< tdclose >}}
{{< tdopen >}}


The immune system and cancer—Cancer Immunoediting hypothesis

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm8" %}}


{{< tdclose >}}
{{< tdopen >}}


Shankaran, V., H. Ikeda, et al. "[IFN gamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity](http://dx.doi.org/10.1038/35074122)." _Nature_ 410, no. 6832 (2001): 1107–11.

Muul, L. M., P. J., Spiess, et al. "[Identification of Specific Cytolytic Immune Responses against Autologous Tumor in Humans Bearing Malignant Melanoma](http://www.ncbi.nlm.nih.gov/pubmed/3100623)." _Journal of Immunology_ 138, no. 3 (1987): 989–95.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
9
{{< tdclose >}}
{{< tdopen >}}


T cell mediated immunotherapy

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm9" %}}


{{< tdclose >}}
{{< tdopen >}}


Attia, P., G. Q. Phan, et al. "[Autoimmunity Correlates with Tumor Regression in Patients with Metastatic Melanoma Treated with Anti–cytotoxic T–Lymphocyte Antigen–4](http://dx.doi.org/10.1200/JCO.2005.06.205)." _Journal of Clnical Oncology_ 23, no. 25 (2005): 6043–53.

Vudattu, N. K., F. Waldron–Lynch, et al. "[Humanized Mice as a Model for Aberrant Responses in Human T Cell Immunotherapy](http://dx.doi.org/10.4049/jimmunol.1302455)." _Journal of Immunology_ 193, no. 2 (2014): 587–96.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
10
{{< tdclose >}}
{{< tdopen >}}


Improving combination chemotherapy and immune–based therapies based on lessons learned from humanized mice

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm10" %}}


{{< tdclose >}}
{{< tdopen >}}


Rambaldi, A., M. Lazzari, et al. "[Monitoring of Minimal Residual Disease after CHOP and Rituximab in Previously Untreated Patients with Follicular Lymphoma](http://dx.doi.org/10.1182/blood.V99.3.856 )." _Blood_ 99, no. 3 (2002): 856–62.

Pallasch, C. P., I. Leskov, et al. "[Sensitizing Protective Tumor Microenvironments to Antibody–mediated Therapy](http://dx.doi.org/10.1016/j.cell.2013.12.041)." _Cell_ 156, no. 3 (2014): 590–602.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
11
{{< tdclose >}}
{{< tdopen >}}


Personalized mice—Part 1: Mouse Avatars

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm11" %}}


{{< tdclose >}}
{{< tdopen >}}


Villarroel, M. C., N. V. Rajeshkumar, et al. "[Personalizing Cancer Treatment in the Age of Global Genomic Analyses: _PALB2_ Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer](http://dx.doi.org/10.1158/1535-7163.MCT-10-0893)." _Molecular Cancer Therapeutics_ 10, no. 1 (2011): 3–8.

Garralda, E., K. Paz, et al. "[Integrated Next–generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment](http://dx.doi.org/10.1158/1078-0432.CCR-13-3047)." _Clinical Cancer Research_ 20, no. 9 (2014): 2476–84.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
12
{{< tdclose >}}
{{< tdopen >}}


Personalized mice—Part 2: Co–clinical trials

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm12" %}}


{{< tdclose >}}
{{< tdopen >}}


Chen, Z., K. Cheng, et al. "[A Murine Lung Cancer Co–clinical Trial Identifies Genetic Modifiers of Therapeutic Response](http://dx.doi.org/10.1038/nature10937)." _Nature_ 483, no. 7391 (2012): 613–17.

Chen, Z., E. Akbay, et al. "[Co–clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in _ALK_–rearranged Non–small Cell Lung Cancer and Predict Strategies to Overcome Resistance](http://dx.doi.org/10.1158/1078-0432.CCR-13-1733)." _Clinical Cancer Research_ 20, no. 5 (2014): 1204–11.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
13
{{< tdclose >}}
{{< tdopen >}}


Class presentation and course evaluation

{{% resource_link 412120c3-d837-bae9-2e73-08a2d78e8810 "See the Lecture Summary" "#Lsumm13" %}}


{{< tdclose >}}
{{< tdopen >}}
No Readings
{{< tdclose >}}

{{< trclose >}}

{{< tableclose >}}